Publications by authors named "Gohei Yagi"

Claim this Profile
D
Discrepancies Between Nomenclature and Indications of Psychotropics.
Fusaka Minami, Joseph Zohar, Takefumi Suzuki, Teruki Koizumi, Masaru Mimura, Gohei Yagi

Pharmacopsychiatry· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mood stabilizers as an Achilles' heel for indication-based nomenclature and roles of Neuroscience-based Nomenclature.
Yuhei Kikuchi, Joseph Zohar, Takefumi Suzuki, Masaru Mimura, Gohei Yagi

Psychiatry Clin Neurosci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Proposal for Natural Resilience Theory in Psychopharmacotherapy: To Deter High-dose Antipsychotic Polypharmacy].
Gohei Yagi, Takefumi Suzuki, Hiroyuki Uchida

Seishin Shinkeigaku Zasshi· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor structure of the targeted inventory on problems in schizophrenia.
Shoji Tanaka, Takanori Nagase, Takefumi Suzuki, Kensuke Nomura, Hiroyoshi Takeuchi, Gohei Yagi

Clin Psychopharmacol Neurosci· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude of rater differences in assessment scales for schizophrenia.
Takefumi Suzuki, Hiroyoshi Takeuchi, Shinichiro Nakajima, Kensuke Nomura, Hiroyuki Uchida, Gohei Yagi

J Clin Psychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, Shinichiro Nakajima, Kensuke Nomura, Gohei Yagi

Hum Psychopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan.
Hiroyuki Uchida, Takefumi Suzuki, David C Mamo, Benoit H Mulsant, Toshiaki Kikuchi, Gohei Yagi

J Anxiety Disord· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).
Takefumi Suzuki, Hiroyuki Uchida, Kensuke Nomura, Hiroyoshi Takeuchi, Shinichiro Nakajima, Gohei Yagi

Schizophr Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Shinichiro Nakajima, Kensuke Nomura, Gohei Yagi

Hum Psychopharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan.
Hiroyuki Uchida, Takefumi Suzuki, David C Mamo, Benoit H Mulsant, Akira Tanabe, Gohei Yagi

Am J Geriatr Psychiatry· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia.
Taishiro Kishimoto, Koichiro Watanabe, Naoki Shimada, Kazuya Makita, Gohei Yagi

J Clin Psychiatry· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Kensuke Nomura, Hiroyoshi Takeuchi, Gohei Yagi

Psychopharmacology (Berl)· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
Kazuo Yamada, Koichiro Watanabe, Naoyuki Nemoto, Hidechika Fujita, Chikayo Chikaraishi, Gohei Yagi

Psychiatry Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder.
Kazuo Yamada, Gohei Yagi, Shigenobu Kanba

Psychiatry Clin Neurosci· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia.
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, Kensuke Nomura, Akira Tanabe, Gohei Yagi

Psychopharmacology (Berl)· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mineral density measurement in female inpatients with schizophrenia.
Taishiro Kishimoto, Koichiro Watanabe, Hiroyoshi Takeuchi, Toshiaki Kikuchi, Shinichiro Nakajima, Gohei Yagi

Schizophr Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is it valid to concurrently use multiple antipsychotics for patients with schizophrenia?].
Takefumi Suzuki, Koichiro Watanabe, Gohei Yagi, Haruo Kashima

Nihon Shinkei Seishin Yakurigaku Zasshi· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia.
Takefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, Kensuke Nomura, Harumasa Takano, Gohei Yagi

Int J Neuropsychopharmacol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Gohei Yagi, Haruo Kashima

Prog Neuropsychopharmacol Biol Psychiatry· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic-induced paroxysmal perceptual alteration.
Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Gohei Yagi, Haruo Kashima

Am J Psychiatry· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia.
Takefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, Masayuki Tomita, Kenichi Tsunoda, Gohei Yagi

Int Clin Psychopharmacol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents.
Hiroyuki Uchida, Takefumi Suzuki, Kenji F Tanaka, Koichiro Watanabe, Gohei Yagi

J Clin Psychopharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.
Toshiya Inada, Hisashi Senoo, Yoshimi Iijima, Tadamitsu Yamauchi, Gohei Yagi

Psychiatr Genet· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: preliminary observations.
Kazuo Yamada, Gohei Yagi, Shigenobu Kanba

Clin Neuropharmacol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
Kazuo Yamada, Gohei Yagi, Shigenobu Kanba

Psychiatry Clin Neurosci· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis